Navigation Links
Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008

e a presentation by CTI on pixantrone and 29 presentations by Biogen Idec and Bayer-Schering on ZEVALIN(R). Selected ZEVALIN presentations are included below.

Date Time Poster # Title



December 8, 5:30 #236-I The Impact of Incorporating Targeted

2007 PM (1082) Radioimmunotherapy (RIT) into

Transplant Preparative Regimens on

the Incidence of Therapy Related

Myelodysplasia (t-MDS) or AML (t-AML)

Following Autologous Stem Cell

Transplant (ASCT) for Lymphoma.

Sunday, 5:15 Oral Session 90Yttrium Ibritumomab Tiuxetan

Dec. 9, PM (22) (Zevalin) Combined with BEAM (Z -

2007 BEAM) Conditioning Regimen Plus

Autologous Stem Cell Transplantation

in Relapsed or Refractory Follicular

Lymphoma. GELA Phase II Study.

Monday, 12:00 Oral Session Phase II Study of R-CHOP Followed by

December 10, PM (389) 90Y-Ibritumomab Tiuxetan in Untreated

2007 Mantle Cell Lymphoma: Eastern

Cooperative Oncology Group Study


Monday, 3:30 Oral Session 90Y-Ibritumomab Tiuxetan (ZEVALIN)

Dec. 10, PM (643) Consolidation of First Remission

2007 in Advanced Stage Follicular

Non-Hodgkins Lymphoma: First Results

of the Internat

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
3. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
9. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
10. Health Plans Increase Use of Health Incentives
11. Area Health Care Providers Announce Plans to Integrate Services
Post Your Comments:
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable source of ... native of Detroit, MI, Kid Rock, is hitting the road again this summer in what ... and hip hop superstar kicked off his summer tour this year at the XFINITY Theatre ...
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
Breaking Medicine News(10 mins):Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... one of them has developed a flesh eating disease; another ... ,Necrotising fasciitis (flesh eating disease) is a rare infectious, ultimately ... spent five weeks in the hospital, and is released now. ... to the officials that the tattooist has to improve the ...
... discovered a protein interaction that may explain how the ... in and featured on the cover of the current ... Huntington’s protein interacts with another protein to cause dramatic ... ,“Cholesterol is essential for promoting the connection network among ...
... could help in fighting cancer,// a recent study issued an ... prone to a relapse of caner in the following cases: ... stem cells are from a female donor. ,This second ... the original transplant. This is more pronounced in them than ...
... Gene Therapy has published the findings of the first ... dysfunction.// The finding shows that gene therapy negates the ... beneficial for months, and hence could be the most ... author Arnold Melman, M.D., professor and chair of the ...
... has shown, in India, a majority of married women are ... Therefore, there is a definite need for protective methods that ... male-controlled methods are not even 20 percent helpful. ,A ... by over-the-counter microbicides, which are gels, creams, films, or suppositories, ...
... been told that patients undergoing chemotherapy in remote areas may ... the patient sending a text of his symptoms according to ... means of a red alert sent to medical staff, or ... of new age technology may be used along with a ...
Cached Medicine News:Health News:Link Between Huntington’s and Abnormal Cholesterol Levels in Brain Establishe 2Health News:The Other Side of Hematopoietic Stem Cell Transplant 2Health News:Gene Therapy May Be the Solution for Erectile Dysfunction 2
(Date:6/30/2015)... 30, 2015 Velos, Inc., the pioneering software ... grow and add customers who receive Clinical and Translational ... CTSAs awarded by the National Institutes of Health currently ... is among the largest such market shares in its ... CTSA community keeps growing as a result of our ...
(Date:6/30/2015)... , June 30, 2015   Millar, Inc. ... technology, today announced the 2016 retirement of Craig ... Directors, after 12 years of service to the Company. ... named two senior members of the Executive Management team ... Tim Daugherty , currently Director of Sales and ...
(Date:6/30/2015)... , June 30, 2015 Olympus, ... innovative solutions for medical and surgical procedures, among ... next-day replacements for surgical equipment at no additional ... to offer this type of guarantee. The service ... Service Agreement earlier this year. ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... 7, 2010 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Review meeting with the U.S. Food and Drug Administration (FDA) ... the Company,s New Drug Application (NDA) for AZ-004 ( Staccato ... FDA in preparation for the meeting, with the responses or ...
... Dec. 7, 2010 Apexigen, Inc. announced today ... worldwide license agreement with Centocor Research & Development, ... therapeutic antibody technologies to discover and develop monoclonal ... to several targets specified by Centocor R&D, which ...
Cached Medicine Technology:Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 2Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 3Apexigen, Inc. Announces Collaboration for Antibody Discovery 2
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: